Related references
Note: Only part of the references are listed.Thyroid abnormalities in patients treated with lenalidomide for hematological malignancies: Results of a retrospective case review
M. Kathleen Figaro et al.
AMERICAN JOURNAL OF HEMATOLOGY (2011)
Radioimmunotherapy of relapsed indolent non-Hodgkin lymphoma with 131I-rituximab in routine clinical practice: 10-year single-institution experience of 142 consecutive patients
Michael F. Leahy et al.
BLOOD (2011)
Hypothyroidism in Patients With Renal Cell Carcinoma Blessing or Curse?
Manuela Schmidinger et al.
CANCER (2011)
Thyroid autoimmunity and ophthalmopathy related to melanoma biological therapy
Le Min et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2011)
Alemtuzumab for the prevention and treatment of graft-versus-host disease
Junya Kanda et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2011)
Thyroid and Hepatic Function After High-Dose 131I-Metaiodobenzylguanidine (131I-MIBG) Therapy for Neuroblastoma
Alekist Quach et al.
PEDIATRIC BLOOD & CANCER (2011)
The natural history of interferon-alpha induced thyroiditis in chronic hepatitis c patients: a long term study
Huy A. Tran et al.
THYROID RESEARCH (2011)
Effects of Evening vs Morning Levothyroxine Intake A Randomized Double-blind Crossover Trial
Nienke Bolk et al.
ARCHIVES OF INTERNAL MEDICINE (2010)
Lenalidomide plus dexamethasone versus thalidomide plus dexamethasone in newly diagnosed multiple myeloma: a comparative analysis of 411 patients
Francesca Gay et al.
BLOOD (2010)
Effect of axitinib (AG-013736) on fatigue, thyroid-stimulating hormone, and biomarkers: A phase I study in Japanese patients
Toru Mukohara et al.
CANCER SCIENCE (2010)
Management of treatment-related adverse events in patients with multiple myeloma
Maria-Victoria Mateos
CANCER TREATMENT REVIEWS (2010)
Thyroid autoimmunity and hypothyroidism during long-term treatment with recombinant interferon-alpha
H. GISSLINGER et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Endocrine side effects of broad-acting kinase inhibitors
Maya B. Lodish et al.
ENDOCRINE-RELATED CANCER (2010)
Sorafenib-Induced Hypothyroidism Is Associated with Increased Type 3 Deiodination
Randa M. Abdulrahman et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Randomized, Double-Blind Trial of Carboplatin and Paclitaxel With Either Daily Oral Cediranib or Placebo in Advanced Non-Small-Cell Lung Cancer: NCIC Clinical Trials Group BR24 Study
Glenwood D. Goss et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Sorafenib and thyrotoxicosis
D. Barbaro
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2010)
Phase 2 Trial of Single Agent Ipilimumab (Anti-CTLA-4) for Locally Advanced or Metastatic Pancreatic Adenocarcinoma
Richard E. Royal et al.
JOURNAL OF IMMUNOTHERAPY (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
The Emerging Toxicity Profiles of Anti-CTLA-4 Antibodies Across Clinical Indications
Anna Maria Di Giacomo et al.
SEMINARS IN ONCOLOGY (2010)
Shrinkage of Thyroid Volume in Sunitinib-Treated Patients with Renal-Cell Carcinoma: A Potential Marker of Irreversible Thyroid Dysfunction?
Aljosja Rogiers et al.
THYROID (2010)
Sunitinib Induces Hypothyroidism with a Markedly Reduced Vascularity
Noriko Makita et al.
THYROID (2010)
Sorafenib-Induced Destructive Thyroiditis
Massimo Iavarone et al.
THYROID (2010)
Thyroid Dysfunction Caused by Second-Generation Tyrosine Kinase Inhibitors in Philadelphia Chromosome-Positive Chronic Myeloid Leukemia
Theo D. Kim et al.
THYROID (2010)
Abnormalities of thyroid function in Japanese patients with metastatic renal cell carcinoma treated with sorafenib: A prospective evaluation
Hideaki Miyake et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2010)
Sunitinib-induced myxedema coma
Shey-Ying Chen et al.
AMERICAN JOURNAL OF EMERGENCY MEDICINE (2009)
Cardiovascular toxicity following sunitinib therapy in metastatic renal cell carcinoma: a multicenter analysis
G. Di Lorenzo et al.
ANNALS OF ONCOLOGY (2009)
Immune reconstitution syndrome and the thyroid
Anthony Weetman
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Drugs that suppress TSH or cause central hypothyroidism
Bryan R. Haugen
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
CTLA4 blockade with ipilimumab to treat relapse of malignancy after allogeneic hematopoietic cell transplantation
Asad Bashey et al.
BLOOD (2009)
Ipilimumab: controversies in its development, utility and autoimmune adverse events
Jeffrey Weber
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Phase I Study of Ipilimumab, an Anti-CTLA-4 Monoclonal Antibody, in Patients with Relapsed and Refractory B-Cell Non-Hodgkin Lymphoma
Stephen M. Ansell et al.
CLINICAL CANCER RESEARCH (2009)
A Randomized, Double-Blind, Placebo-Controlled, Phase II Study Comparing the Tolerability and Efficacy of Ipilimumab Administered with or without Prophylactic Budesonide in Patients with Unresectable Stage III or IV Melanoma
Jeffrey Weber et al.
CLINICAL CANCER RESEARCH (2009)
Direct Effects of Cytostatic Therapy on the Functional State of the Thyroid Gland and TBG in Serum of Patients
S. N Djurica et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2009)
Phase II Study of High-Dose [131I]Metaiodobenzylguanidine Therapy for Patients With Metastatic Pheochromocytoma and Paraganglioma
Sara Gonias et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Phase II Study of Safety and Efficacy of Motesanib in Patients With Progressive or Symptomatic, Advanced or Metastatic Medullary Thyroid Cancer
Martin J. Schlumberger et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Sunitinib-induced thyrotoxicosis
D. Pinar et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2009)
Mechanism of action of lenalidomide in hematological malignancies
Venumadhav Kotla et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2009)
Hypothyroidism related to tyrosine kinase inhibitors: an emerging toxic effect of targeted therapy
Francesco Torino et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2009)
Anti-CTLA4 Antibody-Induced Lupus Nephritis.
Fouad Fadel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Practical recommendations on the use of lenalidomide in the management of myelodysplastic syndromes
Aristoteles Giagounidis et al.
ANNALS OF HEMATOLOGY (2008)
Thyroid function test abnormalities in patients with metastatic renal cell carcinoma treated with sorafenib
I. Tamaskar et al.
ANNALS OF ONCOLOGY (2008)
The clinical implications of sunitinib-induced hypothyroidism:: a prospective evaluation
P. Wolter et al.
BRITISH JOURNAL OF CANCER (2008)
Thyrotoxicosis during sunitinib treatment for renal cell carcinoma
Mathis Grossmann et al.
CLINICAL ENDOCRINOLOGY (2008)
Iodine-131-metaiodobenzylguanidine as initial induction therapy in stage 4 neuroblastoma patients over 1 year of age
Jan de Kraker et al.
EUROPEAN JOURNAL OF CANCER (2008)
Lack of imatinib-induced thyroid dysfunction in a cohort of non-thyroidectomized patients
Jose Miguel Dora et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008)
Documentation of Thyroid Function in Clinical Studies With Sunitinib: Why Does It Matter?
David H. Garfield et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Phase I/II Study of Ipilimumab for Patients With Metastatic Melanoma
Jeffrey S. Weber et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Gestational Choriocarcinoma Mimicking a Uterine Adenocarcinoma
Darren K. Patten et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Phase II trial of sorafenib in advanced thyroid cancer
Vandana Gupta-Abramson et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Alemtuzumab vs. Interferon beta-1a in early multiple sclerosis
Alasdair J. Coles et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Motesanib diphosphate in progressive differentiated thyroid cancer
Steven I. Sherman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Effect of sunitinib on growth and function of FRTL-5 thyroid cells
Andrew K. Salem et al.
THYROID (2008)
Sunitinib-associated lymphocytic thyroiditis without circulating antithyroid antibodies
Doru T. Alexandrescu et al.
THYROID (2008)
Long-term follow-up of relapsing/refractory anti-neutrophil cytoplasm antibody associated vasculitis treated with the lymphocyte depleting antibody alemtuzumab (CAMPATH-1H)
M. Walsh et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Interferon alpha treatment and thyroid dysfunction
Yaron Tomer et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2007)
Ipilimumab (anti-CTLA4 antibody) causes regression of metastatic renal cell cancer associated with enteritis and hypophysitis
James C. Yang et al.
JOURNAL OF IMMUNOTHERAPY (2007)
Sunitinib (sutent)-induced thyrotoxicosis due to destructive thyroiditis: A case report
Jason E. Faris et al.
THYROID (2007)
Sonic hedgehog-induced type 3 deiodinase blocks thyroid hormone action enhancing proliferation of normal and malignant keratinocytes
Monica Dentice et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
A novel tyrosine-kinase selective inhibitor, sunitinib, induces transient hypothyroidism by blocking iodine uptake
Deborah Mannavola et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Transient thyroiditis after treatment with lenalidomide in a patient with metastatic renal cell carcinoma
Emily M. Stein et al.
THYROID (2007)
Phase II trial of thalidomide for therapy of radioiodine-unresponsive and rapidly progressive thyroid carcinomas
Kenneth B. Ain et al.
THYROID (2007)
Bexarotene-induced hypothyroidism: Bexarotene stimulates the peripheral metabolism of thyroid hormones
Johannes W. A. Smit et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
High-dose [131I]tositumomab (anti-CD20) radioimmunotherapy and autologous hematopoietic stem-cell transplantation for adults ≥60 years old with relapsed or refractory B-cell lymphoma
Ajay K. Gopal et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Sunitinib induces hypothyroidism in advanced cancer patients and may inhibit thyroid peroxidase activity
Elaine Wong et al.
THYROID (2007)
Transient hypophysitis after cytotoxic T lymphocyte-associated antigen 4 (CTLA4) blockade
Stephanie A. Shaw et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
The activity of lenalidomide with or without dexamethasone in patients with primary systemic amyloidosis
Angela Dispenzieri et al.
BLOOD (2007)
Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib
Brian I. Rini et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Lenalidomide-associated hypothyroidism
Smitha Menon et al.
LEUKEMIA & LYMPHOMA (2007)
Single-dose rexinoid rapidly and specifically suppresses serum thyrotropin in normal subjects
Wendy M. Golden et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Cancer-related fatigue: The scale of the problem
Maarten Hofman et al.
ONCOLOGIST (2007)
Phase II study of lenalidomide in patients with metastatic renal cell carcinoma
Toni K. Choueiri et al.
CANCER (2006)
Hypothyroidism after sunitinib treatment for patients with gastrointestinal stromal tumors
Jayesh Desai et al.
ANNALS OF INTERNAL MEDICINE (2006)
Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion
Alan List et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Association between development of hypothyroidism and improved survival in patients with head and neck cancer
Marc Nelson et al.
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY (2006)
Multicenter phase II clinical study of iodine-131-rituximab radioimmunotherapy in relapsed or refractory indolent non-Hodgkin's lymphoma
Michael F. Leahy et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Phase II trial of CHOP chemotherapy followed by tositumomab/iodine I-131 tositumomab for previously untreated follicular non-Hodgkin's lymphoma: Five-year follow-up of Southwest Oncology Group protocol S9911
Oliver W. Press et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Minimizing adverse side-effects of oral bexarotene in cutaneous T-cell lymphoma: an expert opinion
C. Assaf et al.
BRITISH JOURNAL OF DERMATOLOGY (2006)
Acting via a cell surface receptor, thyroid hormone is a growth factor for glioma cells
Faith B. Davis et al.
CANCER RESEARCH (2006)
Benign thyroid disease: What is the role of nuclear medicine?
Salil D. Sarkar
SEMINARS IN NUCLEAR MEDICINE (2006)
Intrapatient dose escalation of anti-CTLA-4 antibody in patients with metastatic melanoma
AV Maker et al.
JOURNAL OF IMMUNOTHERAPY (2006)
Thyrotoxicosis after denileukin diftitox therapy in patients with mycosis fungoides
Farah Ghori et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Autoimmune thyroid disease after renal transplantation using depletional induction with alemtuzumab
AD Kirk et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
Effects of rexinoids on thyrotrope function and the hypothalamic-pituitary-thyroid axis
V Sharma et al.
ENDOCRINOLOGY (2006)
VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature
T Kamba et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
The window of therapeutic opportunity in multiple sclerosis
AJ Coles et al.
JOURNAL OF NEUROLOGY (2006)
Antitumor activity in melanoma and anti-self responses in a phase I trial with the anti-cytotoxic T lymphocyte-associated antigen 4 monoclonal antibody CP-675,206
A Ribas et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Long-term risks for thyroid cancer and other neoplasms after exposure to radiation
AB Schneider et al.
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM (2005)
Cytotoxic T-Lymphocyte-associated antigen-4 blockage can induce autoimmune hypophysitis in patients with metastatic melanoma and renal cancer
JA Blansfield et al.
JOURNAL OF IMMUNOTHERAPY (2005)
Imatinib induces hypothyroidism in patients receiving levothyroxinc
JWB de Groot et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
Recent clinical studies of the immunomodulatory drug (IMiD®) lenalidomide
JB Bartlett et al.
BRITISH JOURNAL OF CANCER (2005)
Late thyroid toxicity in 153 long-term survivors of allogeneic bone marrow transplantation for acute lymphoblastic leukaemia
C Berger et al.
BONE MARROW TRANSPLANTATION (2005)
Thyroid hormone and breast carcinoma - Primary hypothyroidism is associated with a reduced incidence of primary breast carcinoma
M Cristofanilli et al.
CANCER (2005)
131I-tositumomab therapy as initial treatment for follicular lymphoma
MS Kaminski et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Type I Interferons modulate the expression of thyroid peroxidase, sodium/iodide symporter, and thyroglobulin genes in primary human thyrocyte cultures
N Caraccio et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Subclinical thyroid disease - Scientific review and guidelines for diagnosis and management
MI Surks et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Severe hypothyroldism after thalidomide treatment
N de Savary et al.
JOURNAL OF THE ROYAL SOCIETY OF MEDICINE (2004)
Safety and efficacy of denileukin diftitox in patients with steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
VT Ho et al.
BLOOD (2004)
Monitoring amiodarone's toxicities: Recommendations, evidence, and clinical practice
HT Stelfox et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
Radiotherapy-induced thyroid disorders
BA Jereczek-Fossa et al.
CANCER TREATMENT REVIEWS (2004)
Effect of iodinated contrast media on thyroid function in adults
AJ van der Molen et al.
EUROPEAN RADIOLOGY (2004)
Etiology, diagnosis, and treatment recommendations for central hypothyroidism associated with bexarotene therapy for cutaneous T-cell lymphoma
SI Sherman
CLINICAL LYMPHOMA (2003)
Remission induction in Behcet's disease following lymphocyte depletion by the anti-CD52 antibody CAMPATH 1-H
CM Lockwood et al.
RHEUMATOLOGY (2003)
Mechanism of selective retinoid X receptor agonist-induced hypothyroidism in the rat
S Liu et al.
ENDOCRINOLOGY (2002)
Hypothyroidism in children with medulloblastoma: A comparison of 3600 and 2340 cGY craniospinal radiotherapy
AC Paulino
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2002)
Induction of myasthenia gravis, myositis, and insulin-dependent diabetes mellitus by high-dose interleukin-2 in a patient with renal cell cancer
PG Fraenkel et al.
JOURNAL OF IMMUNOTHERAPY (2002)
Thyrotoxicosis induced by alpha-interferon therapy in chronic viral hepatitis
V Wong et al.
CLINICAL ENDOCRINOLOGY (2002)
High incidence of thyroid dysfunction despite prophylaxis with potassium iodide during 131I-meta-iodobenzylguanidine treatment in children with neuroblastoma
HM van Santen et al.
CANCER (2002)
Hypothyroidism in patients with multiple myeloma following treatment with thalidomide
AZ Badros et al.
AMERICAN JOURNAL OF MEDICINE (2002)
Interferon in oncological practice: Review of interferon biology, clinical applications, and toxicities
E Jonasch et al.
ONCOLOGIST (2001)
Biologic responses to IFN-α administration in humans
EPM Corssmit et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2000)
Practical guidelines for clinicians who treat patients with amiodarone
N Goldschlager et al.
ARCHIVES OF INTERNAL MEDICINE (2000)
Medicine cabinet - How medications affect thyroid function
BJ Dong
WESTERN JOURNAL OF MEDICINE (2000)